Telos Rx review
The advertised figures belong to the longest plan, and no monthly rate is published for either molecule.
The verdict
Telos Rx publishes $99 a month for compounded semaglutide as its lowest plan-length tier, against a $299 comparison price. No month-to-month rate is published, and standard tirzepatide is $139.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- From $99/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- Not published by the provider
Telos Rx sells both molecules by injection on plan-length tiers, with a separate microdosed tirzepatide product priced below the standard line.
Who writes the prescription, and what do they see?
A prescription precedes shipping and the clinician is not described. The plan structure is the only thing the pages set out in detail, and it omits the rung most readers would start on.
A ladder with no top rung is an unusual shape. A reader can see what the longest commitment costs and cannot see what a single month costs, which reverses the usual disclosure problem — here the cheap figure is real and the expensive one is missing.
What happens when the dose goes up?
Nothing states what either figure does at a higher dose. The microdosed tirzepatide product at $116 is a different treatment rather than a lower rung of the standard $139 line, and the pages keep the two apart.
What the price includes
Six months at $99 is $594 if the longest plan is taken, and nothing on the site establishes what six months costs otherwise. The comparison prices of $299 and $279 sit beside the figures with no stated basis, so they are anchors rather than rates. Standard compounded tirzepatide is $139 a month against a $399 comparison.
What it claims, and what it cites
Both lines are compounded rather than manufactured, prepared by a pharmacy the site does not name, and not reviewed by the FDA before dispensing as an approved product is.
Where it holds up, and where it does not
- Strength: The microdosed product is priced separately
- Strength: The plan-tier structure is stated
- Strength: Both molecules carry a standard figure
- Limitation: No month-to-month rate is published
- Limitation: The advertised figure needs the longest plan
- Limitation: Comparison prices have no stated basis
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about Telos Rx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader taking the longest plan, since no shorter term carries a published rate.
- Wrong for
- A reader who wants to know what a single month costs.
The evidence behind what Telos Rx prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Telos Rx compares
| Seller | Who it suits | Go |
|---|---|---|
 Sumbare Wellness | Readers who will get a molecule-specific figure confirmed before paying | See Sumbare Wellness → |
 StackMD | Readers who want the cost of every dose stated before starting the lowest one | See StackMD → |
 The Edit | Readers who read the standing rate beside the first-order figure | See The Edit → |
More GLP-1 telehealth sellers reviews: ARSYNL RxAscend MedicalAscend VitalityAskRxAspenAspire Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- What does one month cost?
- Not published. The $99 is the lowest plan-length tier and no month-to-month rate appears on the site.
- Is $116 the tirzepatide price?
- That is the separate microdosed product. Standard compounded tirzepatide is listed at $139 a month.
- What are the $299 and $399 figures?
- Comparison prices with no stated basis. Treat them as anchors rather than rates anyone is charged.
- Is Telos Rx expensive compared with other GLP-1 telehealth sellers?
- Telos Rx publishes a starting figure of $99/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Telos Rx below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.